Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial

Kamilla Woznica Miskowiak, Hannelore Ehrenreich, Ellen M Christensen, Lars Vedel Kessing, Maj Vinberg

59 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences